Brain and heart metabolism
Brain and cardiometabolic context
Long-term brain and cardiovascular follow-up often comes back to metabolic systems: glucose control, blood-fat transport, oxidative stress, inflammation, vascular tone, methylation, and cellular energy. This section groups the relevant DNA pathway signals so they can be validated with labs and real-world context.
Use this as a focused checklist for what to measure next. It does not screen for dementia, heart disease, or HCM; it shows which metabolic systems in this sample deserve follow-up.
Blood sugar
Blood-sugar and insulin strain can affect energy stability, vascular load, and long-term cardiometabolic follow-up.
May increase glucose strainValidate with: Fasting insulin, fasting glucose, HbA1cB vitamins
Homocysteine, folate, and B12 context connect this pathway to vascular and nerve-health follow-up.
May lower B-vitamin use efficiencyValidate with: Homocysteine, methylmalonic acid, folateStress recovery
Oxidative-stress buffering matters when inflammation, poor sleep, alcohol, illness, pollution, or heavy training create extra cellular load.
May reduce stress-recovery capacityValidate with: Glutathione balance (GSH/GSSG ratio), oxidized LDLCholesterol / blood fats
ApoB, LDL-C, triglycerides, HDL-C, and Lp(a) show whether lipid-particle transport is visible in current blood chemistry.
May reduce blood-fat clearanceValidate with: ApoB, triglycerides, LDL-CDetox / cleanup
This pathway can add antioxidant-cleanup context when homocysteine, liver markers, recovery, or oxidative-stress markers are relevant.
May reduce cleanup supportValidate with: Homocysteine, liver enzymes, oxidative-stress or recovery contextScored LDL result
LDL and lipid genes tracked in this report
The lipid pathway separates LDL clearance, LDL-receptor regulation, cholesterol synthesis, HDL remodeling, triglyceride-rich particles, sterol transport, and Lp(a) context instead of treating cholesterol as one number.
LDL-C / ApoB follow-up score
May increase LDL-C / ApoB follow-up burden
This sample has more LDL/ApoB-raising evidence than LDL-lowering evidence. The practical next step is lipid blood testing, not assuming disease.
Check ApoB first if possible, plus LDL-C, non-HDL-C, triglycerides, HDL-C, Lp(a), blood pressure, and glucose markers.- LDL/ApoB-raising evidence
- 0.678
- LDL/ApoB-lowering evidence
- 0.298
Raises the LDL/ApoB score
rs2954029 AT carries one TRIB1 rs2954029 A allele and is associated with higher triglyceride-rich and apoB-containing lipid biomarker tendency.
The matched lipid claim points toward higher LDL/ApoB burden.rs4299376 GT carries one ABCG8 rs4299376 G allele and is associated with higher LDL cholesterol and cholesterol-absorption tendency.
The matched lipid claim points toward higher LDL/ApoB burden.rs12916 CT carries one HMGCR rs12916 C allele, the non-LDL-lowering allele relative to T, and is associated with higher LDL cholesterol tendency than TT.
The matched lipid claim points toward higher LDL/ApoB burden.rs688 CT is associated with reduced LDLR transport activity.
Lower LDLR clearance signal raises LDL/ApoB follow-up burden.Offsets the LDL/ApoB score
rs562556 AG carries one PCSK9 rs562556 G allele and is associated with lower LDL cholesterol tendency.
PCSK9 LDL-lowering signal offsets LDL/ApoB follow-up burden.LDL-receptor regulation; PCSK9 changes how many LDL receptors remain available for LDL particle clearance.
Contributes in this sampleLDL particle clearance; LDLR directly removes LDL particles from circulation.
Contributes in this sampleCholesterol synthesis context; HMGCR is the rate-limiting cholesterol-synthesis target used as statin biology context.
Contributes in this sampleTriglyceride-rich and ApoB-containing particle context; TRIB1-region evidence links to triglycerides, LDL-C, and ApoB-containing lipid patterns.
Contributes in this sampleSterol transport and absorption context; ABCG8 affects intestinal and biliary sterol handling and can shift LDL-C tendency.
Contributes in this sampleHDL and lipid remodeling context; CETP changes lipid transfer between HDL and ApoB-containing particles.
Contributes in this sampleCholesterol efflux and HDL formation context; ABCA1 helps move cholesterol out of cells toward HDL particles.
Contributes in this sampleLipid-particle handling context; APOE is tracked as a backup/context gene for lipid transport and brain-lipid discussions.
Tracked as pathway context; no scored contribution in this sampleLipoprotein(a) context; LPA is usually validated directly with an Lp(a) blood test.
Tracked as pathway context; no scored contribution in this sampleApoB particle structure and LDL receptor binding context; ApoB helps define particle burden and LDL clearance biology.
Tracked as pathway context; no scored contribution in this sampleHepatic VLDL-LDL trafficking context; SORT1-region evidence connects liver lipoprotein handling to LDL-C.
Tracked as pathway context; no scored contribution in this sampleHepatic VLDL secretion context; reduced secretion can coexist with liver-lipid retention caveats.
Tracked as pathway context; no scored contribution in this sampleKey lipid checks: ApoBLDL-Cnon-HDL-CtriglyceridesHDL-CLp(a)
Scored cardiac genetics result
HCM / inherited cardiomyopathy screen score
No curated HCM-relevant variant signal was detected in this sample report.
No scored HCM variant signal detected
Clinical-grade follow-up required if history, symptoms, ECG, echo, or MRI raise concern.
This means the current curated evidence registry did not find an HCM-relevant variant in this sample. It does not rule out HCM because consumer raw DNA files do not cover all sarcomeric genes, rare variants, copy-number changes, or clinical interpretation rules.
Scores only direct curated HCM/cardiomyopathy evidence in HCM core or phenocopy genes. Metabolic pathway SNPs and vague cardiomyopathy context are not allowed to create an HCM score.Escalate when present
- Known personal or family history of HCM or unexplained thickened heart muscle
- Family history of sudden unexplained cardiac death, especially at young age
- Fainting, chest pain, abnormal shortness of breath, or palpitations during exertion
- Abnormal ECG, echocardiogram, cardiac MRI, or clinician concern
Genes to discuss
Appropriate follow-up
If HCM is a real question, use cardiology review, ECG/echocardiography or cardiac MRI as appropriate, and clinical-grade cardiomyopathy genetic testing with genetic counseling.
Personal Priority List
What to check first
This view starts with score, priority, and plain meaning. Open any row for markers, practical next steps, and the evidence trail.
| Rank | Pathway | Score | Priority | Plain meaning | Details |
|---|---|---|---|---|---|
| 1 | Coffee / stimulantsCaffeine / stimulant sensitivity | 0.490 | High priority | Coffee may hit hard: wired, shaky, anxious, or awake too long. | |
Personal pathway explanation Coffee / stimulantsCaffeine / stimulant sensitivity Learn about this pathway in the KBHigh priority0.490May increase stimulant sensitivity How to read this score This is about how strongly your body reacts to caffeine and stimulant-like substances. Coffee may hit hard: wired, shaky, anxious, or awake too long. Caffeine / stimulant sensitivity is ranked from 5 matched gene signals and 7 matched evidence items. The strongest matched driver is COMT rs4680 AG; the topology model resolves this as may increase stimulant sensitivity. What to check
Why validateUseful checks include caffeine timing and dose response, sleep latency, resting heart rate, blood pressure response, anxiety or palpitations after caffeine, and wearable sleep/recovery trends. If this pattern fits youStart with dose and timing. If caffeine still feels harsh, consider non-stimulant energy basics first; magnesium or L-theanine may be discussed if sleep or jitteriness is the main issue. Evidence and Audit Trail Genes, SNPs, evidence items, studies, and methodThis pathway-level audit trail shows the 5 matched gene signals, 7 evidence items, source studies, and topology method behind this result. | |||||
| 2 | Lactose digestionLactose digestion | 0.457 | High priority | Your DNA may point toward lower adult lactase activity. Dairy symptoms, dose, fermentation, and gut context decide whether this matters. | |
| 3 | Blood sugarGlucose | 0.442 | High priority | Meals may cause bigger energy crashes, especially after sugar or carbs. | |
| 4 | B vitaminsMethylation | 0.433 | High priority | Your body may use B vitamins less efficiently. This can affect energy, nerves, and repair. | |
| 5 | Stress recoveryOxidative stress | 0.408 | High priority | You may recover more slowly after stress. | |
| 6 | Gluten immune riskGluten / celiac immune risk | 0.399 | High priority | Your DNA may carry more celiac-compatible immune background. This means gluten-related symptoms deserve proper clinical context, not self-diagnosis. | |
| 7 | Cholesterol / blood fatsLipids | 0.363 | High priority | Your body may clear fats from the blood less efficiently. Blood tests decide whether this matters. | |
| 8 | Food / allergy reactionsHistamine | 0.312 | Moderate priority | Those reactions may last longer once they start. | |
| 9 | HormonesEstrogen metabolism | 0.283 | Moderate priority | Estrogen-like hormones may stay in your body longer. | |
| 10 | CholineCholine support | 0.240 | Moderate priority | This sample shows a mild choline-related signal. It may be worth checking if liver markers, methylation context, cognition, diet, or choline intake make it relevant. | |
| 11 | Detox / cleanupSulfur / transsulfuration | 0.164 | Moderate priority | Some detox-related pathways may run less efficiently. This may matter more if symptoms, liver markers, recovery patterns, or sulfur-food sensitivity point in the same direction. | |
| 12 | IronIron handling | 0.115 | Low DNA signal | Iron helps blood carry oxygen. Your iron tests may come back too high. | |